Table 1 Patient characteristics (n = 25)
|  | Mean ± SD Median (interquartile range) |
|---|---|
Age (years) | 69.8 ± 11.3 |
Duration of diabetes (years) | 7.8 ± 5.4 |
Sex (male/female) | 16/9 |
HbA1c (%) | 7.8 ± 0.6 |
FPG (mg/dL) | 175.5 ± 37.2 |
Body weight (kg) | 74.2 ± 19.2 |
BMI (kg/m2) | 28.4 ± 4.9 |
Waist circumference (cm) | 99.2 ± 11.6 |
TG (mg/dL) | 175.0 [147.0–219.0] |
HDL-C (mg/dL) | 47.4 ± 7.1 |
LDL-C (mg/dL) | 91.9 ± 30.4 |
non-HDL-C (mg/dL) | 125.4 ± 31.4 |
FLI | 68.0 ± 22.1 |
Antihyperglycemic drugs | Number (%) |
 Metformin | 16 (64) |
 DPP-4 inhibitor | 21 (84) |
 Sulphonylurea | 6 (24) |
 Glinide | 2 (8) |
 α-Glucosidase inhibitor | 5 (20) |
 Thiazolidinediones | 1 (4) |
 Insulin | 2 (8) |
 GLP-1 receptor agonist | 1 (4) |
Antilipidemic drugs | Â |
 Statins | 15 (60) |
 Fibrates | 1 (4) |
 Intestinal cholesterol absorption inhibitor | 2 (8) |
 Omega-3 fatty acids | 3 (12) |